Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (4986)	12/3/1997 3:53:00 PM
From: aknahow	Respond to of 17367

Pseudo, should be interesting. BTW nice lesson on how to deal with price decline for any biotech management when the facts support ones case, by AGPH. Worth storing away for future reference. Own no AGPH by find co interesting.

To: Pseudo Biologist who wrote (4986)	12/4/1997 12:42:00 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

Pseudo, checking out the Lancet site I looked at Press Release section. Contains reference to longer article in N.Y. Times which I later searched for but could not find. Also contained e-mail address for the author of the original article. Have no reason to waste the authors time with an e- mail, but this in part explains the post from AOL. Apparently someone did e-mail him and got a reply. Learned again that it can pay to look at entire site and the e-mail availability or link may be useful in other situations.